FDA User Fee Bill Eyes Drug Shortages, New Antibiotics

Law360, New York (March 30, 2012, 4:56 PM EDT) -- Provisions aimed at preventing drug shortages and encouraging the development of new antibiotics will likely be included in this year's must-pass bill reauthorizing U.S. Food and Drug Administration user fees, according to drafts released Thursday by a key Senate health committee.

The drafts show that the Senate Committee on Health, Education, Labor and Pensions is considering language that would require drug manufacturers to report any potential shortages to the FDA six months in advance, as well as incentives for drug manufacturers to develop new antibiotics to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.